Paper Details

  1. Home
  2. Paper Details

Evaluation of oral tranexamic acid as a novel treatment for melasma with a high benefit-risk ratio.

Author: PengLucy, SimpsonJordan, TingWilliam

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Melasma, a common hyperpigmentation condition, is often treated with topical agents, lasers, or chemical peels. This article discusses the potential benefits of oral tranexamic acid (TXA) as an alternative treatment option for melasma, particularly in women of reproductive age.
Paper Details　
Original Abstract of the Article :
Melasma is an acquired melanogenesis dysfunction resulting in chronic hyperpigmentation commonly affecting the face and other frequently sun-exposed areas of the body. Melasma typically presents in women of reproductive age and can significantly impact self-esteem, negatively affecting one's quality...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jocd.15305

データ提供：米国国立医学図書館（NLM）

Oral Tranexamic Acid: A Novel Treatment for Melasma with a High Benefit-Risk Ratio

Melasma, a common skin condition characterized by hyperpigmentation, can significantly impact an individual's self-esteem and quality of life. This research explores the potential of oral tranexamic acid (TXA), a drug currently approved for other conditions, as a novel treatment for melasma. The authors highlight the growing use of TXA for hyperpigmentation in East Asian countries and its potential to offer an additional therapeutic option for women in the United States. The study emphasizes the favorable benefit-risk ratio of TXA, suggesting that it could be a safe and effective treatment for melasma.

Oral Tranexamic Acid: A Promising New Treatment for Melasma

The research's findings suggest that oral tranexamic acid (TXA) may be a viable treatment option for melasma, offering women an additional therapeutic avenue to address this common skin condition. This could significantly improve the quality of life for individuals affected by melasma, providing them with a new hope for achieving a more even skin tone.

Navigating Melasma Treatment: A Personalized Approach

Melasma treatment often requires a personalized approach, considering the individual's skin type, severity of the condition, and desired treatment outcomes. This research encourages individuals with melasma to discuss treatment options with a qualified dermatologist to determine the most effective approach for their unique needs.

Dr.Camel's Conclusion

This research provides a compelling case for exploring oral tranexamic acid (TXA) as a potential treatment for melasma. The study's findings suggest that TXA may offer a safe and effective option for individuals seeking to address hyperpigmentation. It's important to remember that individual responses to treatment can vary, and it's always best to consult with a qualified healthcare professional to determine the best course of action.

Date :
  1. Date Completed 2022-12-27
  2. Date Revised 2023-01-03
Further Info :

Pubmed ID

35972476

DOI: Digital Object Identifier

10.1111/jocd.15305

Related Literature

Article Analysis
・Side Effects of tranexamic acid
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.